People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Biotechnology, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neurogastrx, Inc. | — | Biotechnology | Series C | $80.0M | $1.7B | 2021 |
| Ceterix Orthopaedics, Inc. | — | Other Health Care | Series B | $54.4M | $510.5M | 2016 |
| Albamunity, Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.6M | 2020 |
DAVID ALLISON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DAVID ALLISON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kirk Nielsen | 1 | 13 |
| Joshua Makower | 1 | 10 |
| Peter Bisgaard | 1 | 9 |
| SCOTT ROCKLAGE | 1 | 9 |
| Aaron Royston | 1 | 7 |
| Kevin Sidow | 1 | 7 |
| Klaus Veitinger | 1 | 6 |
| Meredith Fisher | 1 | 6 |
| Roger Kitterman | 1 | 5 |
| Charles Warden | 1 | 5 |
| KEVIN KOCH | 1 | 3 |
| Mark Colella | 1 | 2 |
| Justin Saliman | 1 | 2 |
| Paul Rogers | 1 | 2 |
| John McCutcheon | 1 | 2 |
| KLAUS VETTINGER | 1 | 1 |
| JAMES DETORE | 1 | 1 |
| JAMES O'MARA | 1 | 1 |
| CYRIL DE COLLE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.